The agreement allows manufacturers to develop, manufacture and supply generic long-acting injectable cabotegravir for ...

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...

Nearly one million people in Florida have prescriptions to buy medical marijuana, but under a new law, patients who violate the state’s “Drug Abuse Prevention and Control” laws could lose their ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

AbbVie ABBV has been expanding its oncology portfolio over the past few years. While the company was originally focused on two blood-cancer drugs — Imbruvica and Venclexta — it has since built a ...

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's ...